Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, GNI Group's Enterprise Value is $1,069.0 Mil.
GNI Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-16.5 Mil. Therefore, GNI Group's EV-to-OCF for today is -64.94.
The historical rank and industry rank for GNI Group's EV-to-OCF or its related term are showing as below:
GNIIF'
s EV-to-OCF Range Over the Past 10 Years
Min: -470.37 Med: 30.96 Max: 4017.62
Current: -64.07
During the past 13 years, the highest EV-to-OCF of GNI Group was 4017.62. The lowest was -470.37. And the median was 30.96.
GNIIF's EV-to-OCF is ranked better than 94.18% of 1410
companies
in the Biotechnology industry
Industry Median: -3.52
vs GNIIF: -64.07
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GNI Group's share price for today is $15.50.
GNI Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.693.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
GNI Group EV-to-OCF Related Terms
GNI Group EV-to-OCF Historical Data
* Premium members only.
The historical data trend for GNI Group's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, GNI Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GNI Group EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GNI Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where GNI Group's EV-to-OCF falls into.
GNI Group's current Enterprise Value is $1,069.0 Mil.
GNI Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNI Group (GNIIF) has a EV-to-OCF of -64.94 as of Aug. 14, 2026. According to the industry distribution chart, GNI Group ranks #82 out of 1410 companies in the Biotechnology industry, placing it in the top 5.8%.
Is GNI Group's EV-to-OCF too high?
GNI Group's current EV-to-OCF is -64.94. Based on the distribution chart, GNI Group ranks #82 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GNI Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does GNI Group's EV-to-OCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GNI Group ranks #82 out of 1410 companies for EV-to-OCF. This places GNI Group in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. GNI Group's current EV-to-OCF is -64.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GNI Group stock overvalued right now?
GNI Group (GNIIF) has a current EV-to-OCF of -64.94. The stock's GF Value™ is $17.03, compared to a current price of $15.50 — trading 9% below its estimated fair value. The current EV-to-OCF is -64.94. GNI Group's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For GNI Group (GNIIF), the current EV-to-OCF is -64.94 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GNI Group (GNIIF) Overvalued in 2026?
Based on GuruFocus' analysis, GNI Group stock appears to be undervalued.
The current stock price of $15.50 is trading 9% below its estimated GF Value™ of $17.03.
Key valuation signals for GNIIF:
EV-to-OCF: -64.94
GF Value™: $17.03 vs. price of $15.50 (9% below fair value)
No single metric tells the full story. See the GNIIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
86GF Score
Get the complete analysis for GNIIF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GNIIF has been successfully added to your 
